Boosting curcumin’s absorption and effectiveness for disease prevention and therapy

The potential of nano-formulations to boost the bioavailability and bioactivity of curcumin.

Pfizer’s Braftovi extends survival in colorectal cancer

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we take

February 3, 2025

Medicaid is paying millions for salty, fat-laden ‘medically tailored’ cheeseburgers and sandwiches

WASHINGTON – They’re marketed as healthy, “dietitian-approved” meals and delivered directly to the homes of people seriously ill from cancer, diabetes, or heart disease: a

July 11, 2024

Psychedelic Bulletin #145: MAPS’ Second Phase 3 Study Published; EMA’s New Draft Guideline on Depression Drug Dev Includes Psychedelics; California’s Decrim. Bill Goes to Governor – Psychedelic Alpha

The European Medicines Agency’s latest draft Guideline (PDF) on the clinical investigation of medicinal products for the treatment of depression includes a section on psychedelics.

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.